Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Ann Behav Med. 2017 Feb;51(1):67–78. doi: 10.1007/s12160-016-9827-3

Table 4.

Associations of Reported Barriers to Adherence by Regimen Complexity among People on Non-salvage Treatment

Scheduling barriers ART-induced barriers Other barrier

Forgot Too busy Something unexpected came up Making me sick Felt depressed and overwhelmed Got confused with what to take

OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Dosing complexity
STR 1.00 1.00 1.00 1.00 1.00 1.00
Single-dose MTR 1.66(1.14, 2.42)** 1.86(1.21, 2.88)** 1.70(1.10, 2.63)* 3.49(1.38, 8.79)** 2.11(0.98, 4.54) 4.26(0.93, 19.63)
Multi-dose MTR 2.13(1.47, 3.08)*** 2.46(1.61, 3.74)*** 1.78(1.16, 2.74)** 2.82(1.15, 6.92)* 2.22(1.03, 4.82)* 6.10(1.43, 26.13)*
P-value for Trend1 <0.001 <0.001 0.013 0.010 0.062 0.005
Time-invariant covariates
CES-D 1.01(1.00, 1.02)* 1.00(0.99, 1.01) 1.01(0.99, 1.02) 1.01(0.98, 1.03) 1.05(1.03, 1.07)*** 1.01(0.98, 1.04)
Self-efficacy 0.89(0.83, 0.95)*** 0.86(0.80, 0.93)*** 1.33(1.13, 1.56)** 0.85(0.75, 0.96)* 0.89(0.78, 1.00) 0.99(0.83, 1.20)
Time-variant covariates
Time 0 1.00 1.00 1.00 1.00 1.00 1.00
Time 1 0.84(0.66, 1.07) 0.75(0.58, 0.98)* 0.80(0.60, 1.05) 0.72(0.45, 1.13) 0.73(0.45, 1.21) 0.62(0.32, 1.23)
Time 2 0.89(0.70, 1.13) 0.81(0.62, 1.04) 0.85(0.65, 1.10) 0.56(0.34, 0.90)* 0.77(0.46, 1.28) 0.84(0.44, 1.64)
Side-effect 1.23(1.07, 1.41)** 0.86(0.80, 0.93)* 1.3(1.13, 1.56)*** 2.52(2.01, 3.17)*** 1.52(1.15, 2.01)** 1.85(1.33, 2.57)***
1

Testing gradient or curvilinear relationship between dosing complexity and barriers;

*

p<0.05,

**

p<0.01,

***

p<0.001;

STR: single-tablet regimen; MTR: multi-tablet regimen; CES-D: Center for Epidemiologic Studies Depression Scale.